MBP metabolic pharmaceuticals limited

dr livett s website

  1. 182 Posts.
    Livett is the original developer of ACV1. Interesting that he lists some of the other companies working on conotoxins. We are not alone!!!
    http://grimwade.biochem.unimelb.edu.au/cone/index1.html
    All the research abstracts on the index page tell a story too:
    http://grimwade.biochem.unimelb.edu.au/cone/index1.html
    suggests there is a huge race on in the conotoxin field
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.